The Tech Blog Writer Podcast - Inspired Tech Startup Stories & Interviews With Tech Leaders, Entrepreneurs And Innovators

In today’s episode, I had the opportunity to speak with Rafael Carazo Salas, a scientist, entrepreneur, and the CEO and founder of CellVoyant. This is a conversation that goes beyond the hype around AI to reveal how machine learning is reshaping the future of healthcare in ways that are both profound and immediate. CellVoyant, a spinout from the University of Bristol, is using AI and advanced imaging technology to solve one of the most persistent challenges in biotech: the cost, time, and complexity involved in developing cell therapies. Rafael explained how his team is applying real-time microscopy and predictive AI to monitor and guide cell behavior. This approach doesn’t rely on invasive techniques that destroy the very cells being studied. Instead, it enables a clearer path forward in cell therapy development by understanding how cells behave and adapt over time. We explored several impactful examples, from CAR-T therapies for blood cancers to emerging treatments for Parkinson’s disease and type 1 diabete